ViGenCell, Inc. · KRX:308080

ViGenCell, Inc. financial statements

ViGenCell, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in KRW

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue22.7M278.9M00015.0M
Cost of revenue11.6M267.1M0000
Gross profit11.1M11.9M00015.0M
Research and development14.8B11.6B15.5B12.3B6.82B4.42B
Selling, general and administrative407.5M2.92B3.54B1.13B5.38B3.09B2.32B
Operating income-17.1B-15.3B-20.1B-18.2B-13.1B-7.91B-15.0B
Depreciation and amortization2.98B3.33B3.81B2.92B1.72B761.7M101.4M
EBITDA-14.1B-12.0B-16.3B-15.3B-11.4B-7.15B-14.9B
Interest expense318.0M363.6M399.3M289.2M352.7M613.3M0
Income before tax-16.3B-14.1B-17.9B-17.4B-11.1B-10.5B-22.4B
Net income-16.3B-14.1B-17.9B-17.4B-11.1B-10.5B-22.4B
Earnings per share, basic-796.24-729.64-932.68-915.14-588.52-554.19-1,188.98

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash and equivalents3.93B11.1B17.7B8.34B32.1B5.25B16.5B
Short-term investments29.5B34.1B35.7B60.7B33.3B10.9B8.12B
Receivables2.93M256.5M226.4M602.4M63.1M12.1M422.9K
Current assets34.2B45.9B54.4B69.9B66.7B17.7B24.9B
Property, plant and equipment18.8B23.5B27.0B16.1B2.82B862.5M
Total assets54.3B67.3B81.0B99.4B117.0B23.1B26.5B
Current liabilities1.71B8.00B8.47B8.35B10.2B56.3B51.6B
Long-term debt7.40B
Total debt328.0M
Total liabilities10.6B9.32B9.56B9.73B12.1B57.1B51.8B
Shareholders' equity43.7B58.0B71.5B89.6B104.9B-34.1B-25.3B
Shares outstanding20.5M19.3M19.2M19.0M18.9M18.9M18.9M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations-13.8B-10.9B-15.3B-11.1B-7.95B-8.19B-2.96B
Capital spending-821.8M-112.5M-1.02B-13.7B-11.5B-1.77B-987.5M
Free cash flow-14.6B-11.0B-16.3B-24.8B-23.4B-9.97B-3.95B
Cash from investing4.11B24.3B-10.9B-68.7B-2.65B-6.19B
Cash from financing169.5M296.7M-1.82B103.6B-379.4M20.0B
Share buybacks215.6M314.0M78.5M95.2B20.0B
Change in cash-7.14B-6.62B9.35B-23.8B26.9B-11.2B10.8B